Abstract
Inflammatory bowel disease includes ulcerative colitis and Crohn’s disease, and is globally increasing. An appropriate model system is required to dissect the disease pathogenesis and drugs screening for adequate treatment. In the present study, we established a novel model of gut inflammation by injecting peptidoglycan from Staphylococcus aureus using laparotomic procedure. For this, three different doses of peptidoglycan, i.e., 2.5, 5 and 10 mg/kg body weight were used. The treatment effect was evaluated by studying the macrophage phagocytic function, spleen lymphocytes’ proliferation and qRT-PCR for the assessment of peritoneal cells’ gene expression. In addition, histological analysis of gut sections, gastric acidity, immunoglobulins and cytokines were assessed. There was significant increase in phagocytic activity in 10 mg/kg body weight PGN group. A dose dependent increase in spleen lymphocytes’ proliferation and a significant increase in total acid secretion in 5 and 10 mg/kg body weight PGN treated rats were observed. In addition, a significant increment in TLR-2 and CD-14 mRNA expression in peritoneal cells, TNF-α, IL-6 and IFN-γ level and maximum distortion of gut architecture was observed in 10 mg/kg body weight PGN group. Hence, peptidoglycan from S. aureus can be used for establishing the screening model to study the action and mechanism of anti-inflammatory food products and drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data can be available only on the request.
References
Anbazhagan AN, Priyamvada S, Alrefai WA et al (2018) Pathophysiology of IBD associated diarrhea. Tissue Barrier 6:1–21
Cominelli F, Arseneau KO, Rodriguez-Palacios A et al (2017) Uncovering pathogenic mechanisms of inflammatory bowel disease using mouse models of Crohn’s disease-like ileitis: what is the right model? Cell Mol Gastroenterol Hepatol 4:19–32
Dang AK, Prasad S, De K et al (2012) Effect of supplementation of vitamin E, copper and zinc on the in vitro phagocytic activity and lymphocyte proliferation index of peripartum Sahiwal (Bos indicus) cows. J Anim Physiol Anim Nutr 97:315–321
Egger B, Bajaj-Elliott M, MacDonald TT et al (2000) Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62:240–248
Eweka A, Om’iniabohs F (2011) Histological studies of the effects of monosodium glutamate on the ovaries of adult wistar rats. Ann Med Health Sci Res 1:37–43
Fiebiger U, Bereswill S, Heimesaat MM (2016) Dissecting the interplay between intestinal microbiota and host immunity in health and disease: lessons learned from germfree and genobiotic animal models. Eur J Microbiol Immunol 6:253–271
Gold MR, Carol L, Miller T et al (1985) Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions. Infect Immun 49:731–741
Im E, Riegler FM, Pothoulakis C et al (2012) Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice. Am J Physiol Gastrointest Liver Physiol 303:G490–G497
Irwin R, Raehtz S, Parameswaran N et al (2016) Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol 311(6):R1149–R1157
Larmonier CB, Shehab KW, Ghishan FK et al (2015) T Lymphocyte dynamics in inflammatory bowel diseases: role of the microbiome. Biomed Res Int 2015:504638
Lee SH, Kwon J, Cho M (2018) Immunological pathogenesis of inflammatory bowel disease. Intes Res 16:26–42
Liu Y, Wang Y, Yamakuchi M et al (2001) Up regulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa beta activation. Infect Immun 69:2788–2796
McDonald C, Inohara N, Nuñez G (2005) Peptidoglycan signaling in innate immunity and inflammatory disease. J Biol Chem 280:20177–20180
McDowell C, Farooq U, Haseeb M (2022) Inflammatory bowel disease. StatPearls Publishing, Treasure Island
Melgar S, Karlsson A, Michaelsson E (2005) Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288:G1328–G1338
Peluso I, Palmery M (2016) The relationship between body weight and inflammation: lesson from anti-TNF-α antibody therapy. Hum Immunol 77:47–53
Rahal K, Schmiedlin-Ren P, Adler J et al (2012) Resveratrol has anti-inflammatory and antifibrotic effects in the peptidoglycan polysaccharide rat model of Crohn’s disease. Inflamm Bowel Dis 18:613–623
Randhawa PK, Singh K, Singh N et al (2014) A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol 18:279–288
Sabiu S, Garubab T, Sunmonuc T et al (2015) Indomethacin-induced gastric ulceration in rats: protective roles of Spondias mombin and Ficus exasperate. Toxicol Rep 2:261–267
Sharma R, Kapila R, Haq MRU et al (2014) Age-associated aberrations in mouse cellular and humoral immune responses. Aging Clin Exp Res 36:1–17
Wang JE, Jorgensen PF, Almlof M et al (2000) Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor-alpha, interleukin 6 (IL-6) and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun 68:3965–3970
Wroblewski LE, Peek RM, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713–739
Yao X, Smolka AJ (2019) Gastric parietal cell physiology and Helicobacter pylori-induced disease. Gastroenterology 156:2158–2173
Acknowledgements
We are thankful to Director, National Dairy Research Institute, Karnal, India for providing financial support and laboratory facilities to carry out this work.
Funding
The study received no funding grant from any funding organization.
Author information
Authors and Affiliations
Contributions
DS performed experiments and wrote the paper. KR and KS designed the experiments, analyse the data and wrote the paper.
Corresponding author
Ethics declarations
Conflict of interest
All authors have no competing interest.
Additional information
Communicated by Yusuf Akhter.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Devi, S., Kapila, R. & Kapila, S. A novel gut inflammatory rat model by laparotomic injection of peptidoglycan from Staphylococcus aureus. Arch Microbiol 204, 684 (2022). https://doi.org/10.1007/s00203-022-03294-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00203-022-03294-x